Commonwealth Equity Services LLC Sells 7,397 Shares of Haleon plc (NYSE:HLN)

Commonwealth Equity Services LLC decreased its position in Haleon plc (NYSE:HLN) by 3.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 215,604 shares of the company’s stock after selling 7,397 shares during the period. Commonwealth Equity Services LLC’s holdings in Haleon were worth $2,057,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Procyon Advisors LLC raised its stake in shares of Haleon by 41.3% in the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock valued at $2,196,000 after purchasing an additional 67,329 shares in the last quarter. HighTower Advisors LLC increased its holdings in Haleon by 27.2% in the 3rd quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after buying an additional 74,970 shares during the period. Jane Street Group LLC raised its stake in shares of Haleon by 1,689.4% in the 3rd quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock valued at $2,803,000 after buying an additional 250,169 shares in the last quarter. Townsquare Capital LLC lifted its holdings in shares of Haleon by 29.8% during the 3rd quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock worth $5,032,000 after acquiring an additional 109,217 shares during the period. Finally, Bank of New York Mellon Corp boosted its position in shares of Haleon by 29.8% during the 4th quarter. Bank of New York Mellon Corp now owns 2,071,017 shares of the company’s stock valued at $19,758,000 after acquiring an additional 475,934 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Trading Up 0.7 %

HLN opened at $10.12 on Friday. Haleon plc has a 1-year low of $7.99 and a 1-year high of $10.80. The firm has a 50-day moving average price of $9.92 and a two-hundred day moving average price of $9.88. The stock has a market capitalization of $45.81 billion, a PE ratio of 29.76, a PEG ratio of 2.82 and a beta of 0.25. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The firm had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. As a group, equities analysts anticipate that Haleon plc will post 0.43 earnings per share for the current fiscal year.

Haleon Increases Dividend

The company also recently declared a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be paid a dividend of $0.1166 per share. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, April 25th. This is a positive change from Haleon’s previous — dividend of $0.05. Haleon’s dividend payout ratio is 58.97%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on HLN. HSBC reissued a “hold” rating on shares of Haleon in a research report on Wednesday, March 5th. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Haleon in a report on Monday, March 3rd. Finally, Hsbc Global Res lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Six equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Haleon currently has an average rating of “Hold” and a consensus target price of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.